SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVictrex Regulatory News (VCT)

Share Price Information for Victrex (VCT)

Share Price is delayed by 15 minutes
Get Live Data
620.00    9.00 (1.47%)
Bid:
621.00
Ask:
623.00
Spread: 2.00 (0.322%)
Market Cap: £540.17m
VCT Live PriceLast checked at - London Stock Exchange

Intraday Victrex Share Chart

Directorate Change

20 May 2014 07:00

RNS Number : 5238H
Victrex PLC
20 May 2014
 



May 20, 2014

Victrex plc: Chairman succession

 

Anita Frew to retire after serving on the Board for 14 years; 6 as Chairman

 

Victrex plc, an innovative world leader in high performance polymer solutions, announces that Anita Frew will retire as Non-Executive Chairman of Victrex plc on 30 September 2014, after serving on the Board for 14 years, including 6 as Chairman. Anita will be succeeded as Chairman by Lawrence (Larry) Pentz, currently a Non-Executive Director of the Company. The search for the role of Chairman covered both internal and external candidates and was led by Giles Kerr, the Senior Independent Director.

Larry was appointed to the Victrex Board in 2008 and currently chairs its Risk Committee. He has over 30 years' service within multi-national corporations in a variety of operational and general management positions. Larry has extensive experience in developing strategy for and successfully leading international growth businesses, and has been instrumental in the acquisition and integration of multiple catalyst and chemical companies for Johnson Matthey, where he remains an Executive Director.

Anita Frew, current Chairman of Victrex, said: "I'm delighted that Larry has accepted the Board's invitation to succeed me as Chairman of Victrex. He brings invaluable and relevant industry experience, and a deep knowledge of the sector and Victrex's strategic markets.

"It has been an honour to chair Victrex, one of Britain's great industrial manufacturing companies and a true export champion. I feel privileged to have been able to build and lead an outstanding Board and executive team. Victrex has a clear strategy, a culture of innovation, technical leadership, a strong financial position and our timely investment in new capacity will support our continuing commercial success and growth."

Larry Pentz said: "We will certainly miss Anita's leadership as Chairman of Victrex and I feel privileged to have the opportunity to succeed her and build on her work. Anita's contribution to the company over 14 years, particularly the last 6 years as Chairman, has been invaluable and we wish her well. The business remains well positioned to drive further growth and create value over the coming years and I look forward to working with the Board and the wider Victrex team."

Upon his appointment as Chairman, Larry will also become Chair of the Nominations Committee.

Enquiries:

Victrex plc:

Andrew Hanson, Head of Investor Relations +44 1253 898121

Anita Frew, Chairman +44 1253 897700

Larry Pentz, Non-Executive Director +44 1253 897700

David Hummel, Chief Executive +44 1253 897700

 

 

 

 

About Victrex:

Victrex is an innovative world leader in high performance polymer solutions. Every day, millions of people rely on products or applications which contain our materials, from smartphones, aeroplanes and cars to oil & gas operations and medical devices. With over 35 years' experience, we are focusing on technical excellence to deliver new and leading edge solutions to our customers and our markets, and to drive value for our shareholders. Find out more at www.victrexplc.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAEAXSNFSKLEFF
Date   Source Headline
29th May 202611:00 amRNSTotal Voting Rights
18th May 20268:50 amRNSDirectorate change
11th May 20267:00 amRNSHalf-year Financial Report
30th Apr 202610:46 amRNSTotal Voting Rights
29th Apr 20264:28 pmRNSHolding(s) in Company
31st Mar 20261:37 pmRNSTotal Voting Rights
24th Mar 20264:29 pmRNSHolding(s) in Company
24th Mar 20262:03 pmRNSHolding(s) in Company
20th Mar 20269:38 amRNSHolding(s) in Company
27th Feb 20262:40 pmRNSTotal Voting Rights
27th Feb 20261:02 pmRNSHolding(s) in Company
24th Feb 202611:41 amRNSHolding(s) in Company
17th Feb 20263:06 pmRNSDirector/PDMR Shareholding
12th Feb 20263:26 pmRNSDirector/PDMR Shareholding
12th Feb 20263:22 pmRNSDirector/PDMR Shareholding
10th Feb 20262:43 pmRNSDirector/PDMR Shareholding
10th Feb 20269:00 amRNSDirectorate change
6th Feb 20261:33 pmRNSResult of AGM
6th Feb 20267:00 amRNSQ1 Trading Update
30th Jan 202611:49 amRNSTotal Voting Rights
28th Jan 202612:25 pmRNSHolding(s) in Company
22nd Jan 202610:21 amRNSHolding(s) in Company
20th Jan 20261:26 pmRNSAdditional Listing
31st Dec 20259:00 amRNSTotal Voting Rights
31st Dec 20259:00 amRNSTotal Voting Rights
22nd Dec 202512:00 pmRNSAnnual Financial Report
22nd Dec 202512:00 pmRNSAnnual Financial Report
18th Dec 202511:49 amRNSDirector/PDMR Shareholding - Replacement
17th Dec 20253:42 pmRNSDirector/PDMR Shareholding
17th Dec 202512:08 pmRNSDirector/PDMR Shareholding
15th Dec 20259:00 amRNSDirector/PDMR Shareholding
11th Dec 20258:52 amRNSDirector/PDMR Shareholding
5th Dec 20259:30 amRNSShare purchase by incoming Director (incoming CEO)
4th Dec 20259:06 amRNSFinancial Calendar Update
2nd Dec 20257:00 amRNSPreliminary Results
1st Dec 202510:49 amRNSBlock listing Interim Review
28th Nov 20259:27 amRNSTotal Voting Rights
20th Nov 20259:05 amRNSAdditional Listing
7th Nov 202510:39 amRNSHolding(s) in Company
31st Oct 20258:58 amRNSTotal Voting Rights
21st Oct 20257:30 amRNSCEO Succession update
3rd Oct 202511:36 amRNSHolding(s) in Company
3rd Oct 20259:03 amRNSHolding(s) in Company
30th Sep 20259:54 amRNSTotal Voting Rights
29th Aug 202510:16 amRNSTotal Voting Rights
31st Jul 20259:14 amRNSTotal Voting Rights
9th Jul 20251:02 pmRNSHolding(s) in Company
8th Jul 20253:33 pmRNSDirector/PDMR Shareholding
8th Jul 20257:00 amRNSDirectorate change: CEO succession
8th Jul 20257:00 amRNSQ3 Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.